Lucia Pokrievkova

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Tacrine (THA), the first clinically effective acetylcholinesterase (AChE) inhibitor and the first approved drug for the treatment of Alzheimer's disease (AD), was withdrawn from the market due to its side effects, particularly its hepatotoxicity. Nowadays, THA serves as a valuable scaffold for the design of novel agents potentially applicable for AD(More)
  • 1